Related Experiment Video
Updated: Jan 23, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
New Lectins from Mediterranean Flora. Activity against HT29 Colon Cancer Cells
Isabel Oliveira1,2, António Nunes3,4, Ana Lima5
1Department of Toxicological and Bromatological Sciences (DCTB), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, Portugal. ioliveira2@campus.ul.pt.
Abstract:
Experiments conducted in vitro and in vivo, as well as some preclinical trials for cancer therapeutics, support the antineoplastic properties of lectins. A screening of antitumoral activity on HT29 colon cancer cells, based on polypeptide characterization and specific lectin binding to HT29 cells membrane receptors, was performed in order to assess the bioactivities present in four Mediterranean plant species: Juniperus oxycedrus subsp. oxycedrus, Juniperus oxycedrus subsp. badia, Arbutus unedo and Corema album. Total leaf proteins from each species were evaluated with respect to cell viability and inhibitory activities on HT29 cells (cell migration, matrix metalloproteinase -MMP proteolytic activities). A discussion is presented on a possible mechanism justifying the specific binding of lectins to HT29 cell receptors. All species revealed the presence of proteins with affinity to HT29 cell glycosylated receptors, possibly explaining the differential antitumor activity exhibited by the two most promising species, Juniperus oxycedrus subsp. badia and Arbutus unedo.
Insights
Mediterranean plants show potential as cancer therapeutics. Leaf proteins from Juniperus and Arbutus species exhibit antitumoral activity against colon cancer cells by binding to cell receptors.
Area of Science:
- Phytochemistry
- Pharmacology
- Oncology
Background:
- Lectins possess demonstrated antineoplastic properties, supported by in vitro, in vivo, and preclinical cancer therapeutic studies.
- Mediterranean flora represents a rich source of bioactive compounds with potential medicinal applications.
Purpose of the Study:
- To screen the antitumoral activity of four Mediterranean plant species against HT29 colon cancer cells.
- To characterize polypeptides and assess lectin binding to HT29 cell membrane receptors.
- To evaluate the bioactivities of leaf proteins from selected plants.
Main Methods:
- Screening of antitumoral activity on HT29 colon cancer cells.
- Polypeptide characterization and specific lectin binding assays.
- Evaluation of total leaf proteins for effects on cell viability, migration, and matrix metalloproteinase (MMP) activity.
Main Results:
- All tested plant species contained proteins with affinity for HT29 cell glycosylated receptors.
- Significant differential antitumor activity was observed, with Juniperus oxycedrus subsp. badia and Arbutus unedo showing the most promise.
- Leaf proteins affected HT29 cell viability and inhibited cell migration and MMP proteolytic activities.
Conclusions:
- Proteins from Mediterranean plants, particularly Juniperus oxycedrus subsp. badia and Arbutus unedo, exhibit potential as colon cancer therapeutics.
- Specific lectin binding to HT29 cell receptors is a likely mechanism for the observed antitumor effects.
- Further investigation into these plant lectins could lead to novel cancer treatment strategies.
Related Concept Videos
Bacterial Flora of the Large Intestine
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.
The Colonization of Land
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Cancer Cell Migration through Invadopodia
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

